O-Glycosyl Flavonoid Solubility via L-Arginine Complexation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods to enhance the water solubility of O-glycosyl flavonoids, such as isoquercitrin and rutin, either alter their natural form or result in unstable modifications, limiting their pharmaceutical and cosmetic applications due to low solubility.

Innovation Solution

A composition is prepared by mixing glycosyl compounds like isoquercitrin or rutin with L-arginine in specific molar ratios and concentrations, then agitated at controlled temperatures to create a formulation with significantly improved water solubility, allowing for enhanced pharmacokinetic profiles and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If invasive chemical or enzymatic modification is used to improve water solubility, then water solubility is improved, but the natural form of the glycosyl flavonoid is altered

Engineering Contradiction:
Improvewater solubilityVSAvoidnatural form integrity
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

L-arginine serves as an intermediary substance that forms a complex with glycosyl flavonoids, enabling improved water solubility without chemically modifying the flavonoid structure. The L-arginine acts as a mediator that bridges the hydrophobic flavonoid and hydrophilic water environment through non-covalent interactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite system consisting of L-arginine and glycosyl flavonoid in a specific molar ratio (1:1.6 to 1:3.0). This composite material combines the properties of both components, where L-arginine enhances water solubility while the glycosyl flavonoid maintains its natural therapeutic properties.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If non-invasive salt or co-crystal polymorph formation is used to improve water solubility, then water solubility is improved, but the modified forms are unstable

Engineering Contradiction:
Improvewater solubilityVSAvoidstability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

L-arginine acts as a stable intermediary that forms a soluble complex with the glycosyl flavonoid through non-covalent interactions. This complex remains stable in aqueous solution and can be stored without degradation, unlike traditional salt or co-crystal forms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the physical-chemical parameters of the system by controlling the molar ratio of L-arginine to glycosyl flavonoid (1:1.6 to 1:3.0) and the agitation temperature (90°C or lower). These parameter optimizations ensure both high solubility and stability of the composition.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If high temperature agitation is used to improve solubility, then water solubility is improved, but degradation of the glycosyl flavonoid may occur

Engineering Contradiction:
Improvewater solubilityVSAvoidglycosyl flavonoid stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The invention optimizes the temperature parameter by limiting agitation temperature to 90°C or lower. This temperature control achieves sufficient solubility enhancement while preventing thermal degradation of the heat-sensitive glycosyl flavonoid structure.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves water solubility of glycosyl compounds at least 300 times higher than conventional methods, enabling superior pharmacokinetic profiles and stability, making them suitable for pharmaceutical, medical, and cosmetic use without altering their natural form.

Implementation Method 1

mixing the glycosyl compound with an aqueous solution of L-arginine to form a mixture, in which the glycosyl compound and L-arginine are present in a molar ratio of 1:1.6 to 1:3.0

Methodology Applied
Scientific EffectComplex formation:

Implementation Method 2

agitating the mixture at a temperature of 90° C. or lower

Methodology Applied
Scientific EffectDissolution: Solvation

Data Source

PatentUS11266671B2Compositions of O-glycosyl flavonoids
Publication Date: 2022.03.08 ALPS PHARMA IND CO LTD
  • US11266671B2 patent drawing
  • US11266671B2 patent drawing
  • US11266671B2 patent drawing

AI summary

A composition containing L-arginine and a glycosyl compound of formula (I):in which R is a moiety formed of a monosaccharide, a disaccharide, or an oligosaccharide including three to five monosaccharides; and the composition contains the glycosyl compound and L-arginine in a molar ratio of 1:1.6 to 1:3.0. Also disclosed is a method for preparing such a composition, as well as a composition prepared by the method.